ERA4TB – Closing the gap between early bacterial activity and clinical cure
-
Chair(s):
Dr. Santiago Ramon Garcia,
ARAID Investigator, ARAID Foundation/University of Zaragoza, Fac, Medicine Dept, Microbiology, Zaragoza, SpainProf. Oscar Della Pasqua
Chair Clinical Pharmacology & Therapeutics,University College London, London, United Kingdom -
Session description:
Novel in vitro tools to inform pre-clinical and clinical progression of TB combination therapy
Dr Santiago Ramon Garcia
ARAID Investigator, ARAID Foundation/ University of Zaragoza, Fac, Medicine Dept, Microbiology, Zaragoza, SpainTreatment relapse: interaction between the immune system and anti-tubercular drugs
Oscar Della Pasqua
Chair Clinical Pharmacology, University College London, London, United KingdomSelection of companion drugs and dose rationale for combination therapy
Dr Silvia Grandoni
Post-doctoral Fellow, National Research Council, Rome, ItalyModelling of the immune response and prediction of treatment relapse
Dr Filippo Castiglione
Adjunct Professor, Roma Tre University, Rome, ItalyUnderstanding drug distribution in lung tissue, lesion and granulomasistribution
Dr Aris Dokoumetzidis
Assistant Professor, "Athena" Research and Innovation Center, Athens, Greece
Speakers
-
Dr Aris DokoumetzidisAssistant Professor,"Athena" Research and Innovation Center, Athens, Greece
-
Dr Filippo CastiglioneAdjunct Professor,Roma Tre University, Rome, Italy
-
Dr Santiago Ramon GarciaARAID Investigator, ARAID Foundation/University of Zaragoza, Fac, Medicine Dept, Microbiology, Zaragoza, Spain
-
Dr Silvia GrandoniPost-doctoral Fellow,National Research Council, Rome, Italy
-
Oscar Della PasquaChair Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom
Leave A Comment